Investigating the effects of platelets, platelet releasate and aspirin on colorectal cancer cell proliferation, migration and invasion
Open Access
- 7 February 2026
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 43 (3) , 144
Abstract
The aims of this study were to investigate the binding of platelets to colorectal cancer (CRC) cells, platelet activation by CRC cells, and determine the effect of platelets and platelet releasate containing extracellular vesicles on CRC cell proliferation, migration and invasion following aspirin pretreatment. Platelets from healthy individuals were pretreated with aspirin before co-incubation with CRC cells. Platelet activation by CRC cells was analysed by flow cytometry and the binding of platelets to CRC cells investigated using immunofluorescence microscopy. Platelet releasate containing extracellular vesicles was generated by centrifugation. The effect of platelets and platelet releasate on CRC cell proliferation was investigated using carboxyfluorescein succinimidyl esterand dimethylthiazol-carboxymethoxyphenyl-sulfophenyl-tetrazolium assays. Migration and invasion were examined using Transwell assays. HCT15 and HCT116 CRC cells activated platelets, with higher numbers of CRC cells activating more platelets, however aspirin was unable to inhibit platelet activation. Platelets are also able to bind to HCT15 and HCT116 cells. Platelets and platelet releasate did not affect HCT15 and HCT116 proliferation, however, aspirin directly inhibited the proliferation of both cell lines. Platelets and platelet releasate significantly increased the migration and invasion of HCT116, but not HCT15 cell lines. Platelets adhere to and are activated by CRC cells lines, with aspirin unable to inhibit this activation. CRC proliferation was not affected by platelets, however the effect on cancer cell migration and invasion was dependent upon the cell line, suggesting the effects of platelets and platelet releasate containing extracellular vesicles may be patient specific. The inhibitory effect of aspirin on colorectal cancer proliferation is a direct effect on the cancer cell and independent of platelets and extracellular vesicles.Keywords
Funding Information
- University of New South Wales
This publication has 37 references indexed in Scilit:
- Analysis of the Healthy Platelet Proteome Identifies a New Form of Domain-Specific O-FucosylationMolecular & Cellular Proteomics, 2024
- Platelet-derived extracellular vesicles regulate cell cycle progression and cell migration in breast cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- Population-wide Impact of Long-term Use of Aspirin and the Risk for CancerJAMA Oncology, 2016
- A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityCell, 2016
- Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro studyGastric Cancer, 2015
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cellsCancer Detection Prevention, 2007
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994